Nanostics and OncoHelix Partner to Provide ClarityDX Prostate for Men at Risk of Having Aggressive Prostate Cancer in the Middle East Miscellaneous news Nanostics and OncoHelix Partner to Provide ClarityDX Prostate for Men at Risk of Having Aggressive Prostate Cancer in the Middle East Karren Franco 27 September، 2024 EDMONTON, Alberta & CALGARY, Alberta Nanostics Inc., a precision health company developing diagnostic tests with its ClarityDX®... Read More Read more about Nanostics and OncoHelix Partner to Provide ClarityDX Prostate for Men at Risk of Having Aggressive Prostate Cancer in the Middle East
